Curriculum Vitaes

Tamae Ohye

  (大江 瑞恵)

Profile Information

Affiliation
Professor, School of Health Sciences Faculty of Medical Technology, Fujita Health University
Degree
医学博士(藤田保健衛生大学)

Researcher number
10247661
J-GLOBAL ID
200901075566829507
researchmap Member ID
1000289405

External link

染色体異常の発生機構について研究しています。

Papers

 106
  • 佐藤 倫, 倉橋 浩樹, 大江 瑞恵, 佐藤 労
    DNA多型, 31(1) 128-133, Jul, 2023  
  • 奥野 桜子, 藤江 里衣子, 河村 理恵, 倉橋 浩樹, 大江 瑞恵, 佐藤 労
    日本遺伝カウンセリング学会誌, 43(2) 137-137, Jun, 2022  
  • Tasuku Mariya, Takema Kato, Takeshi Sugimoto, Syunsuke Miyai, Hidehito Inagaki, Tamae Ohye, Eiji Sugihara, Yukako Muramatsu, Seiji Mizuno, Hiroki Kurahashi
    Journal of human genetics, 67(6) 363-368, Jan 14, 2022  Peer-reviewed
    Structural analysis of small supernumerary marker chromosomes (sSMCs) has revealed that many have complex structures. Structural analysis of sSMCs by whole genome sequencing using short-read sequencers is challenging however because most present with a low level of mosaicism and consist of a small region of the involved chromosome. In this present study, we applied adaptive sampling using nanopore long-read sequencing technology to enrich the target region and thereby attempted to determine the structure of two sSMCs with complex structural rearrangements previously revealed by cytogenetic microarray. In adaptive sampling, simple specification of the target region in the FASTA file enables to identify whether or not the sequencing DNA is included in the target, thus promoting efficient long-read sequencing. To evaluate the target enrichment efficiency, we performed conventional pair-end short-read sequencing in parallel. Sequencing with adaptive sampling achieved a target enrichment at about a 11.0- to 11.5-fold higher coverage rate than conventional pair-end sequencing. This enabled us to quickly identify all breakpoint junctions and determine the exact sSMC structure as a ring chromosome. In addition to the microhomology and microinsertion at the junctions, we identified inverted repeat structure in both sSMCs, suggesting the common generation mechanism involving replication impairment. Adaptive sampling is thus an easy and beneficial method of determining the structures of complex chromosomal rearrangements.
  • 日比野ゆかり, 西澤春紀, 山岡貴花, 佐々木典子, 佐藤労, 大江瑞恵
    日本遺伝カウンセリング学会誌, 43(2) 127-127, 2022  Peer-reviewedCorresponding author
  • Hiroki Miura, Yoshiki Kawamura, Tamae Ohye, Fumihiko Hattori, Kei Kozawa, Masaru Ihira, Hiroshi Yatsuya, Haruki Nishizawa, Hiroki Kurahashi, Tetsushi Yoshikawa
    The Journal of Infectious Diseases, 223(10) 1717-1723, May 28, 2021  Peer-reviewed
    <title>Abstract</title> <sec> <title>Background</title> Human herpesvirus 6 (HHV-6) can be genetically transmitted from parent to child as inherited chromosomally integrated HHV-6 (iciHHV-6). HHV-6 reactivation occurs in pregnant women with iciHHV-6. We found no sex differences in the frequency of index cases with iciHHV-6 but inheritance from the father was more common. We evaluated the association between iciHHV-6 status and spontaneous abortion. </sec> <sec> <title>Methods</title> iciHHV-6 was confirmed by high viral DNA copy numbers in whole blood and somatic cells. The origin of integrated viral genome, paternal or maternal, was examined using the same method. The pregnancy history of 23 mothers in families with iciHHV-6 and 285 mothers in families without iciHHV-6 was abstracted. </sec> <sec> <title>Results</title> Of 23 iciHHV-6 index cases, 8 mothers and 15 fathers had iciHHV-6. Spontaneous abortion rates in mothers with and mothers without/fathers with iciHHV-6 and mothers in families without iciHHV-6 were 27.6%, 10.3%, and 14.8%, respectively (P = .012). Mothers with iciHHV-6 (odds ratio [OR], 6.41; 95% confidence interval [CI], 1.10–37.4) and maternal age at the most recent pregnancy ≥40 years (OR, 3.91; 95% CI, 1.30–11.8) were associated with 2 or more spontaneous abortions. </sec> <sec> <title>Conclusions</title> Mothers with iciHHV-6 is a risk factor for spontaneous abortion. </sec>
  • Hiroki Doi, Taei Matsui, Johannes M Dijkstra, Atsushi Ogasawara, Yuki Higashimoto, Seiji Imamura, Tamae Ohye, Hiromu Takematsu, Itsuro Katsuda, Hidehiko Akiyama
    F1000Research, 10 542-542, 2021  Peer-reviewed
    Background: Andrographolide (Andro) is a diterpenoid component of the plant Andrographis paniculata that is known for its anti-tumor activity against a variety of cancer cells.   Methods: We studied the effects of Andro on the viability of the human leukemia monocytic cell line THP-1 and the human multiple myeloma cell line H929. Andro was compared with cytosine arabinoside (Ara-C) and vincristine (VCR), which are well-established therapeutics against hematopoietic tumors. The importance of reactive oxygen species (ROS) production for the toxicity of each agent was investigated by using an inhibitor of ROS production, N-acetyl-L-cysteine (NAC).    Results:  Andro reduced the viability of THP-1 and H929 in a dose-dependent manner. H929 viability was highly susceptible to Andro, although only slightly susceptible to Ara-C. The agents Andro, Ara-C, and VCR each induced apoptosis, as shown by cellular shrinkage, DNA fragmentation, and increases in annexin V-binding, caspase-3/7 activity, ROS production, and mitochondrial membrane depolarization. Whereas Ara-C and VCR increased the percentages of cells in the G0/G1 and G2/M phases, respectively, Andro showed little or no detectable effect on cell cycle progression. The apoptotic activities of Andro were largely suppressed by NAC, an inhibitor of ROS production, whereas NAC hardly affected the apoptotic activities of Ara-C and VCR.  Conclusions: Andro induces ROS-dependent apoptosis in monocytic leukemia THP-1 and multiple myeloma H929 cells, underlining its potential as a therapeutic agent for treating hematopoietic tumors. The high toxicity for (thus forming: The high toxicity for H929 cells, by a mechanism that is different from that of Ara-C and VCR, is encouraging for further studies on the use of Andro against multiple myeloma.) H929 cells, by a mechanism that is different from that of Ara-C and VCR, is encouraging for further studies on the use of Andro against multiple myeloma.
  • Katsuya Miyajima, Chiaki Kawamoto, Satoshi Hara, Masayo Mori-Kojima, Tamae Ohye, Chiho Sumi-Ichinose, Nae Saito, Toshikuni Sasaoka, Daniel Metzger, Hiroshi Ichinose
    Journal of Biological Chemistry, 296 100544-100544, Jan, 2021  Peer-reviewed
  • Kento Inoue, Hiroki Miura, Akihiro Hoshino, Takahiro Kamiya, Kay Tanita, Tamae Ohye, Myoung‐Ja Park, Masakatsu Yanagimachi, Masatoshi Takagi, Kohsuke Imai, Tomohiro Morio, Tetsushi Yoshikawa, Hirokazu Kanegane
    Transplant Infectious Disease, 22(5) e13331, Oct, 2020  
    Human herpesvirus-6 (HHV-6) is a common pathogen affecting the human population. Primary HHV-6 infection generally occurs during infancy and causes exanthema subitum. Moreover, HHV-6 may exhibit inherited chromosomally integrated HHV-6 (iciHHV-6) in certain individuals. Although iciHHV-6 is generally known to be nonpathogenic, it may cause reactivation in patients with primary immunodeficiency disease (PID). XIAP deficiency is a rare PID characterized by recurrent hemophagocytic lymphohistiocytosis (HLH). It has been reported that the Epstein-Barr virus primarily causes HLH; however, the other pathogens, including HHV-6, can also cause this complication. We encountered a case of XIAP deficiency accompanied by iciHHV-6. He suffered from recurrent HLH, for which allogeneic bone marrow transplantation (BMT) was performed as a curative therapy. During the course of BMT, the patient experienced HLH three times, but there was no reactivation of endogenous HHV-6 from iciHHV-6. Finally, the patient achieved complete donor chimerism and a decline in HHV-6 DNA copy number in whole blood. This case report demonstrates no evidence of reactivation of iciHHV-6 during BMT in a patient with XIAP deficiency.
  • Hiroki Miura, Tamae Ohye, Kei Kozawa, Fumihiko Hattori, Yoshiki Kawamura, Masaru Ihira, Hiroki Kurahashi, Tetsushi Yoshikawa
    Journal of the Pediatric Infectious Diseases Society, 10(2) 175-178, Jan 23, 2020  Peer-reviewed
    Immunocompetent sisters with chromosomally integrated human herpesvirus 6A (HHV-6A) transiently excreted HHV-6B genome in their saliva. They did not have past histories of exanthema subitum but had antibodies against HHV-6A and HHV-6B. This suggests that endogenous HHV-6A may modify the clinical features of HHV-6B coinfection.
  • Katsuyuki Yokoi, Yoko Nakajima, Tamae Ohye, Hidehito Inagaki, Yoshinao Wada, Tokiko Fukuda, Hideo Sugie, Isao Yuasa, Tetsuya Ito, Hiroki Kurahashi
    JIMD reports, 43 85-90, 2019  Peer-reviewed
    Phosphoglucomutase 1 (PGM1) deficiency is a recently defined disease characterized by glycogenosis and a congenital glycosylation disorder caused by recessive mutations in the PGM1 gene. We report a case of a 12-year-old boy with first-cousin parents who was diagnosed with a PGM1 deficiency due to significantly decreased PGM1 activity in his muscle. However, Sanger sequencing revealed no pathogenic mutation in the PGM1 gene in this patient. As this case presented with a cleft palate in addition to hypoglycemia and elevated transaminases and creatine kinase, karyotyping was performed and identified homozygous inv(1)(p31.1p32.3). Based on the chromosomal location of the PGM1 gene at 1p31, we analyzed the breakpoint of the inversion. Fluorescence in situ hybridization (FISH) combined with long PCR analysis revealed that the inversion disrupts the PGM1 gene within intron 1. Since the initiation codon in the PGM1 gene is located within exon 1, we speculated that this inversion inactivates the PGM1 gene and was therefore responsible for the patient's phenotype. When standard molecular testing fails to reveal a mutation despite a positive clinical and biochemical diagnosis, the presence of a gross structural variant that requires karyotypic examination must be considered.
  • Miura H, Kawamura Y, Hattori F, Kozawa K, Ihira M, Ohye T, Kurahashi H, Yoshikawa T
    Journal of medical virology, 90(10) 1636-1642, Oct, 2018  Peer-reviewed
    The objectives of the work are to elucidate the incidence and virological findings of chromosomally integrated human herpesvirus 6 (ciHHV-6) in Japanese population and to analyze an association between ciHHV-6 and the clinical manifestation of exanthema subitum (ES). Real-time polymerase chain reaction was performed to determine HHV-6 DNA loads in 2347 cord blood samples from healthy neonates (cohort A), febrile children less than 5 years old (cohort B), and hematopoietic cell transplant recipients (cohort C). CiHHV-6 was confirmed by detection of high copy numbers of viral DNA in somatic cells. The integration site was determined by fluorescent in situ hybridization analysis. In the ciHHV-6 subjects of cohorts A and B, HHV-6 antibody titers were measured, the history of ES was obtained, and the incidence of ES was compared with non-ciHHV-6 children without primary HHV-6B infection in the cohort B. CiHHV-6 was detected in 14 (0.60%) of the 2347 samples: A (6/1006, 0.60%), B (6/790, 0.76%), and C (2/551, 0.36%). The integration sites were on chromosome 22q in seven cases, Yp in two cases, and 17q and Xp in one case. No past history of ES was observed in 11 of the 12 subjects. Nine children with ciHHV-6 underwent serological analysis and were found to be positive for HHV-6 IgG antibodies. Incidence of ES was statistically higher in the control subjects than the ciHHV-6 subjects (P = 0.0039). In Japan, the frequency of ciHHV-6 was 0.60%. A high incidence of ciHHV-6A, specifically in chromosome 22, is a characteristic finding among the Japanese. CiHHV-6 may interfere with the clinical symptoms of primary HHV-6B infection.
  • Hiroki Doi, Taei Matsui, Tamae Ohye, Seiji Imamura, Yuki Higashimoto, Jun Yukitake, Kuniaki Saito, Itsuro Katsuda, Hidehiko Akiyama
    Fujita Medical Journal, 4(3) 55-60, 2018  Peer-reviewed
  • Yoshiki Kawamura, Tamae Ohye, Hiroki Miura, Masaru Ihira, Yuri Kato, Hiroki Kurahashi, Tetsushi Yoshikawa
    JOURNAL OF GENERAL VIROLOGY, 98(7) 1823-1830, Jul, 2017  Peer-reviewed
  • Yuji Yamada, Tomoo Osumi, Ken-Ichi Imadome, Etsuko Takahashi, Tamae Ohye, Tetsushi Yoshikawa, Daisuke Tomizawa, Motohiro Kato, Kimikazu Matsumoto
    TRANSPLANT INFECTIOUS DISEASE, 19(1), Feb, 2017  Peer-reviewed
  • Hiroki Doi, Taei Matsui, Tamae Ohye, Kuniaki Saito, Itsuro Katsuda, Hidehiko Akiyama
    Fujita Medical Journal, 3(3) 48-54, 2017  Peer-reviewed
    <p>Objectives: Andrographis paniculata (A. paniculata) is a widely used herb that has potential medical properties. Andrographolide (Andro) is the major component of A. paniculata. We evaluated the anti-tumor activity of Andro using leukemic cell line cells.</p><p>Methods: Leukemic cell lines U937, HL60 or H929 cells were cultured in the presence or absence of Andro and compared with the effects of Ara-C or vincristine. The anti-tumor activity was assessed by morphological observations of the cells, DNA fragmentation, MTT assay, Annexin V positive rate, caspase-3/7 activity, and cell cycle analysis.</p><p>Results: After addition of Andro, the morphology of cells changed to characteristic shapes with apoptotic bodies. Furthermore, the Annexin V positive rate and caspase-3/7 activities were increased compared with untreated cells. The G1 phase of cell cycle was also similarly increased compared with cells treated with Ara-C.</p><p>Conclusions: Our results show that Andro has an anti-tumor activity against leukemic cell lines, very possibly by inducing apoptosis.</p>
  • Hidehito Inagaki, Takema Kato, Makiko Tsutsumi, Yuya Ouchi, Tamae Ohye, Hiroki Kurahashi
    FRONTIERS IN GENETICS, 7 125, Jul, 2016  Peer-reviewed
  • Tamae Ohye, Yoshiki Kawamura, Hidehito Inagaki, Akiko Yoshikawa, Masaru Ihira, Tetsushi Yoshikawa, Hiroki Kurahashi
    JOURNAL OF VIROLOGICAL METHODS, 228 74-78, Feb, 2016  Peer-reviewed
  • Takaiso N, Nishizawa H, Nishiyama S, Sawada T, Hosoba E, Ohye T, Sato T, Inagaki H, Kurahashi H
    Fujita Medical Journal, 2(3) 59-61, 2016  Peer-reviewed
    <p>  The genetic etiology of female infertility is almost completely unknown. Recently, the egg membrane protein JUNO was identified as a receptor of the sperm-specific protein IZUMO1 and their interaction functions in sperm-egg fusion in fertilization. In the present study, we examined 103 women with infertility of unknown etiology. We analyzed the JUNO gene in these cases by PCR and Sanger sequencing. We identified seven variants in total: four common, two synonymous, and a previously unidentified intronic mutation. However, it is not clear from these variants that JUNO has a major role, if any, in infertility. Many factors affect sterility and a larger cohort of patients will need to be screened in the future because the cause of female infertility is highly heterogeneous.</p>
  • 稲垣 秀人, 宮村 浩徳, 大江 瑞恵, 堤 真紀子, 加藤 武馬, 西澤 春紀, 倉橋 浩樹
    日本生化学会大会・日本分子生物学会年会合同大会講演要旨集, 88回・38回 [3P0611]-[3P0611], Dec, 2015  
  • Jun Miyazaki, Mayuko Ito, Haruki Nishizawa, Takema Kato, Yukito Minami, Hidehito Inagaki, Tamae Ohye, Masafumi Miyata, Hiroko Boda, Yuka Kiriyama, Makoto Kuroda, Takao Sekiya, Hiroki Kurahashi, Takuma Fujii
    BMC MEDICAL GENETICS, 16 98, Oct, 2015  Peer-reviewed
  • H. Miura, Y. Kawamura, K. Kudo, M. Ihira, T. Ohye, H. Kurahashi, N. Kawashima, K. Miyamura, N. Yoshida, K. Kato, Y. Takahashi, S. Kojima, T. Yoshikawa
    TRANSPLANT INFECTIOUS DISEASE, 17(5) 728-731, Oct, 2015  Peer-reviewed
  • H Yagasaki, H Shichino, N Shimizu, T Ohye, H Kurahashi, T Yoshikawa, S Takahashi
    Transpl Infect Dis, 17(1) 160-161, Feb, 2015  
  • H. Yagasaki, H. Shichino, N. Shimizu, T. Ohye, H. Kurahashi, T. Yoshikawa, S. Takahashi
    TRANSPLANT INFECTIOUS DISEASE, 17(1) 160-161, Feb, 2015  Peer-reviewed
  • Tsuge I, Morishita M, Kato T, Tsutsumi M, Inagaki H, Mori Y, Yamawaki K, Inuo C, Ieda K, Ohye T, Hayakawa A, Kurahashi H
    Human genome variation, 2 15003-15003, 2015  Peer-reviewed
    Ichthyosis prematurity syndrome (IPS) is a rare autosomal recessive disorder characterized by prematurity, a thick caseous scale at birth and lifelong atopic diathesis. Here, we describe the first Japanese case of IPS and report novel compound heterozygous mutations (p.C403Y and p.R510H) in fatty acid transport protein 4 (FATP4). She is the first reported patient of Asian origin, entirely distinct from the Scandinavian population, in whom the heterozygote carrier frequency is very high.
  • Yatsuka Hibi, Tamae Ohye, Kimio Ogawa, Yoshimi Shimizu, Masahiro Shibata, Chikara Kagawa, Yutaka Mizuno, Shinya Uchino, Shinji Kosugi, Hiroki Kurahashi, Katsumi Iwase
    SURGERY TODAY, 44(11) 2195-2200, Nov, 2014  Peer-reviewed
  • Akifumi Endo, Ken Watanabe, Tamae Ohye, Kyoko Suzuki, Tomoyo Matsubara, Norio Shimizu, Hiroki Kurahashi, Tetsushi Yoshikawa, Harutaka Katano, Naoki Inoue, Kohsuke Imai, Masatoshi Takagi, Tomohiro Morio, Shuki Mizutani
    Clin. Infect. Dis., 59(4) 545-548, Aug, 2014  Peer-reviewed
  • Akifumi Endo, Ken Watanabe, Tamae Ohye, Kyoko Suzuki, Tomoyo Matsubara, Norio Shimizu, Hiroki Kurahashi, Tetsushi Yoshikawa, Harutaka Katano, Naoki Inoue, Kohsuke Imai, Masatoshi Takagi, Tomohiro Morio, Shuki Mizutani
    CLINICAL INFECTIOUS DISEASES, 59(4) 545-548, Aug, 2014  Peer-reviewed
  • Tamae Ohye, Hidehito Inagaki, Takema Kato, Makiko Tsutsumi, Hiroki Kurahashi
    PEDIATRICS INTERNATIONAL, 56(4) 462-466, Aug, 2014  Peer-reviewed
  • Tamae Ohye, Hidehito Inagaki, Mamoru Ozaki, Toshiro Ikeda, Hiroki Kurahashi
    JOURNAL OF HUMAN GENETICS, 59(5) 247-250, May, 2014  Peer-reviewed
  • Makiko Tsutsumi, Reiko Fujiwara, Haruki Nishizawa, Mayuko Ito, Hiroshi Kogo, Hidehito Inagaki, Tamae Ohye, Takema Kato, Takuma Fujii, Hiroki Kurahashi
    PLOS ONE, 9(5) e96710, May, 2014  Peer-reviewed
  • Tamae Ohye, Hidehito Inagaki, Masaru Ihira, Yuki Higashimoto, Koji Kato, Junko Oikawa, Hiroshi Yagasaki, Takahiro Niizuma, Yoshiyuki Takahashi, Seiji Kojima, Tetsushi Yoshikawa, Hiroki Kurahashi
    SCIENTIFIC REPORTS, 4 4559, Apr, 2014  Peer-reviewed
  • Ikuya Tsuge, Komei Ito, Tamae Ohye, Naoyuki Kando, Yasuto Kondo, Yoichi Nakajima, Chisato Inuo, Hiroki Kurahashi, Atsuo Urisu
    PEDIATRIC PULMONOLOGY, 49(3) E52-E55, Mar, 2014  Peer-reviewed
  • Yatsuka Hibi, Tamae Ohye, Kimio Ogawa, Yoshimi Shimizu, Masahiro Shibata, Chikara Kagawa, Yutaka Mizuno, Hiroki Kurahashi, Katsumi Iwase
    ENDOCRINE JOURNAL, 61(1) 19-23, Jan, 2014  Peer-reviewed
  • Junko Oikawa, Junko Tanaka, Tetsushi Yoshikawa, Yoshinori Morita, Haruka Hishiki, Naruhiko Ishiwada, Tamae Ohye, Hiroki Kurahashi, Yoichi Kohno
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 20(1-2) 65-67, Jan, 2014  Peer-reviewed
  • Ohye T, Kurahashi H
    Nihon Geka Gakkai zasshi, 115(1) 34-38, Jan, 2014  
  • Yu Liang, Hidehito Inagaki, Qinyu Hao, Masaru Sakamoto, Tamae Ohye, Takahiro Suzuki, Hiroshi Ichinose
    Biochemical and Biophysical Research Communications, 442(1-2) 72-78, Dec 6, 2013  Peer-reviewed
  • Branko Aleksic, Itaru Kushima, Tamae Ohye, Masashi Ikeda, Shohko Kunimoto, Yukako Nakamura, Akira Yoshimi, Takayoshi Koide, Shuji Iritani, Hiroki Kurahashi, Nakao Iwata, Norio Ozaki
    Scientific reports, 3 2587-2587, 2013  Peer-reviewed
    Using a very high-resolution oligonucleotide array for copy number variant (CNV) screening of samples comprising schizophrenic patients, we detected a novel CNV within the critical region (NCBI36/hg18, Chr7: 158,630,410-158,719,410) previously shown to be associated with schizophrenia. We investigated the association between the novel CNV identified in the current study and schizophrenia. Three independent samples were used: (1) Screening set, 300 Japanese schizophrenic patients (53.28 ± 14.66 years); (2) Confirmation set, 531 schizophrenic patients (46.03 ± 12.15 years); and (3) 711 healthy controls (47.12 ± 11.03 years). All subjects enrolled in the study were Japanese. Chromosomal position was determined using fluorescence in situ hybridization. We identified a novel duplication within the region associated with schizophrenia identified on 7q36.3 that is adjacent to VIPR2 and is not associated with schizophrenia. In the Japanese population, the 35-kb region that harbors the common, novel CNV should be excluded from the region associated with schizophrenia on 7q36.3.
  • Hidehito Inagaki, Tamae Ohye, Hiroshi Kogo, Makiko Tsutsumi, Takema Kato, Maoqing Tong, Beverly S. Emanuel, Hiroki Kurahashi
    Nature Communications, 4 1592, 2013  Peer-reviewed
  • Hiroshi Kogo, Makiko Tsutsumi, Hidehito Inagaki, Tamae Ohye, Hiroshi Kiyonari, Hiroki Kurahashi
    GENES TO CELLS, 17(11) 897-912, Nov, 2012  Peer-reviewed
  • Makiko Tsutsumi, Hiroe Kowa-Sugiyama, Hasbaira Bolor, Hiroshi Kogo, Hidehito Inagaki, Tamae Ohye, Kouji Yamada, Mariko Taniguchi-Ikeda, Tatsushi Toda, Hiroki Kurahashi
    JOURNAL OF HUMAN GENETICS, 57(8) 515-522, Aug, 2012  Peer-reviewed
  • Hiroshi Kogo, Makiko Tsutsumi, Tamae Ohye, Hidehito Inagaki, Takaya Abe, Hiroki Kurahashi
    GENES TO CELLS, 17(6) 439-454, Jun, 2012  Peer-reviewed
  • Hiroki Kurahashi, Makiko Tsutsumi, Sachie Nishiyama, Hiroshi Kogo, Hidehito Inagaki, Tamae Ohye
    CONGENITAL ANOMALIES, 52(1) 8-15, Mar, 2012  Peer-reviewed
  • Hiroki Kurahashi, Tamae Ohye, Hidehito Inagaki, Hiroshi Kogo, Makiko Tsutsumi
    JOURNAL OF HUMAN GENETICS, 57(2) 81-83, Feb, 2012  Peer-reviewed
  • Ikemoto K, Suzuki T, Ichinose H, Ohye T, Nishimura A, Nishi K, Nagatsu I, Nagatsu T
    Brain Res., 954(2) 237-246, 2012  Peer-reviewed
  • Hiroki Kurahashi, Hiroshi Kogo, Makiko Tsutsumi, Hidehito Inagaki, Tamae Ohye
    Frontiers in Genetics, 3 112, 2012  Peer-reviewed
  • Takema Kato, Hidehito Inagaki, Maoqing Tong, Hiroshi Kogo, Tamae Ohye, Kouji Yamada, Makiko Tsutsumi, Beverly S. Emanuel, Hiroki Kurahashi
    MOLECULAR CYTOGENETICS, 4 18, Sep, 2011  Peer-reviewed
  • Makiko Tsutsumi, Hiroshi Kogo, Hiroe Kowa-Sugiyama, Hidehito Inagaki, Tamae Ohye, Hiroki Kurahashi
    BIOLOGY OF REPRODUCTION, 85(1) 165-171, Jul, 2011  Peer-reviewed
  • Kurahashi H, Inagaki H, Ohye T, Kogo H, Tsutsumi M, Kato T, Tong M, Emanuel BS
    Clinical genetics, 78(4) 299-309, Oct, 2010  Peer-reviewed
  • Tamae Ohye, Hidehito Inagaki, Hiroshi Kogo, Makiko Tsutsumi, Takema Kato, Maoqing Tong, Merryn V. E. Macville, Livija Medne, Elaine H. Zackai, Beverly S. Emanuel, Hiroki Kurahashi
    EUROPEAN JOURNAL OF HUMAN GENETICS, 18(7) 783-787, Jul, 2010  Peer-reviewed
  • Maoqing Tong, Takema Kato, Kouji Yamada, Hidehito Inagaki, Hiroshi Kogo, Tamae Ohye, Makiko Tsutsumi, Jieru Wang, Beverly S. Emanuel, Hiroki Kurahashi
    HUMAN MOLECULAR GENETICS, 19(13) 2630-2637, Jul, 2010  Peer-reviewed

Misc.

 142

Presentations

 4

Teaching Experience

 9

Research Projects

 13

Other

 4
  • FISH法による染色体解析(FISH法による染色体の数的異常や欠失、挿入などの構造異常の解析、Ohye T, scientific reports, 2014)
  • その他教育活動上特記すべき事項 なし
  • 教育方法・教育実践に関する発表、講演等 なし
  • 教育内容・方法の工夫(授業評価等を含む) なし